Nitrofurantoin-p-aminobenzoic acid cocrystal: Hydration stability and dissolution rate studies

Journal of Pharmaceutical Sciences

Volumn 100, Issue 8, 2011, Pages 3233-3244

  Cherukuvada, Suryanarayan ^a   Babu, N Jagadeesh ^a   Nangia, Ashwini ^a  

^a UNIVERSITY OF HYDERABAD   (India)

Author keywords

Antibacterial; Co crystal; Hydration; Intrinsic dissolution rate; Nitrofurantoin; Polymorph; Solubility; Stability; Transformation; X ray diffractometry

Indexed keywords

4 AMINOBENZOIC ACID; ARGININE; NITROFURANTOIN; UREA;

ARTICLE; CRYSTAL STRUCTURE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; DRUG STABILITY; HYDRATION; HYDROGEN BOND; THERMOGRAVIMETRY; X RAY DIFFRACTION; X RAY POWDER DIFFRACTION;

EID: 79958799403     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22546     Document Type: Article

References (36)

1. Miller-Hjelle MA, Somaraju V, Hjelle JT. 1997. In Modern pharmacology with clinical applications; Craig CR, Stitzel RE, Eds. 5th ed. Boston: Little Brown & Company, pp 515-525.
2. WHO model list of Essential Medicines. last accessed March 10th 2011.
3. Marshall PV, York P. 1989. Crystallization solvent induced solid-state and particulate modifications of nitrofurantoin. Int J Pharm 55:257-263.
4. Otsuka M, Teraoka R, Matsuda Y. 1991. Physicochemical properties of nitrofurantoin anhydrate and monohydrate and their dissolution. Chem Pharm Bull 39:2667-2670.
5. Pienaar EW, Caira MR, Lötter AP. 1993. Polymorphs of nitrofurantoin. 2. Preparation and X-ray crystal structures of two anhydrous forms of nitrofurantoin. J Crystallogr Spectr Res 23:785-790.
6. Pienaar EW, Caira MR, Lötter AP. 1993. Polymorphs of nitrofurantoin. 1. Preparation and X-ray crystal structures of two monohydrated forms of nitrofurantoin. J Crystallogr Spectr Res 23:739-744.
7. Caira MR, Pienaar EW, Lötter AP. 1996. Polymorphism and pseudopolymorphism of the antibacterial nitrofurantoin. Mol Cryst Liq Cryst 279:241-264.
8. Kasim NA, Whitehouse M, Ramachandran C, Bermejo M, Lennernas H, Hussain AS, Junginger HE, Stavchansky SA, Midha KK, Shah VP, Amidon GL. 2004. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm 1:85-96.
9. Paul HE, Kenyon JH, Paul MF, Borgmann AR. 1967. Laboratory studies with nitrofurantoin. Relationship between crystal size, urinary excretion in the rat and man, and emesis in dogs. J Pharm Sci 56:882-885.
10. http://www.pfizer.com.au/ProductInfo.aspx.
11. Tian F, Qu H, Louhi-Kultanen M, Rantanen J. 2009. Mechanistic insight into the evaporative crystallization of two polymorphs of nitrofurantoin monohydrate. J Cryst Growth 311:2580-2589.
12. Sandler N, Rantanen J, Heinämäki J, Römer M, Marvola M, Yliruusi J. 2005. Pellet manufacturing by extrusion-spheronization using process analytical technology. AAPS PharmSciTech 6:E174-E183.
13. Wikström H, Rantanen J, Gift AD, Taylor LS. 2008. Toward an understanding of the factors influencing anhydrate-to-hydrate transformation kinetics in aqueous environments. Cryst Growth Des 8:2684-2693.
14. Koradia V, Diego HLD, Elema MR, Rantanen J. 2010. Integrated approach to study the dehydration kinetics of nitrofurantoin mononhydrate. J Pharm Sci 99:3966-3976.
15. Otsuka M, Teraoka R, Matsuda Y. 1992. Rotating-disk dissolution kinetics of nitrofurantoin anhydrate and monohydrate at various temperatures. Pharm Res 9:307-311.
16. Gever G, Vincent JG. 1962. Improvements in or relating to nitrofurantoin salts. PatentGB 902692, PatentUS 3007846.
17. Deboeck AM, Fossion JJ, Smolders RR. 1982. Nitrofurantoin salts, their preparation and their use Sels de nitrofurantoine, leur preparation et leur utilization. European Patent 0066934.
18. Shan N, Zaworotko MJ. 2008. The role of cocrystals in pharmaceutical science. Drug Discov Today 13:440-446.
19. Childs SL, Zaworotko MJ. 2009. The reemergence of cocrystals: The crystal clear writing is on the wall. Introduction to virtual issue on pharmaceutical cocrystals. Cryst Growth Des 9:4208-4211.
20. Stanton MK, Kelly RC, Colletti A, Kiang YH, Langley M, Munson EJ, Peterson ML, Roberts J, Wells M. 2010. Improved pharmacokinetics of AMG 517 through co-crystallization Part 1: Comparison of two acids with corresponding amide co-crystals. J Pharm Sci 99:3769-3778.
21. Karki S, Friščić T, Fábián L, Laity PR, Day GM, Jones W. 2009. Improving mechanical properties of crystalline solids by cocrystal formation: New compressible forms of paracetamol. Adv Mater 21:3905-3909.
22. Trask AW, Motherwell WDS, Jones W. 2005. Pharmaceutical cocrystallization: Engineering a remedy for caffeine hydration. Cryst Growth Des 5:1013-1021.
23. Desiraju GR. 1995. Supramolecular synthons in crystal engineering-A new organic synthesis. Angew Chem Int Ed Engl 34:2311-2327.
24. Walsh RDB, Bradner MW, Fleischman S, Morales LA, Moulton B, Rodríguez-Hornedo N, Zaworotko MJ. 2003. Crystal engineering of the composition of pharmaceutical phases. Chem Commun 2:186-187.
25. Byrn SR, Pfeiffer RR, Stowell JG. 1999. Solid-state chemistry of drugs. 2nd ed. West Lafayette, Indiana: SSCI, Inc., pp 233-247.
26. Shan N, Toda F, Jones W. 2002. Mechanochemistry and co-crystal formation: Effect of solvent on reaction kinetics. Chem Commun 20:2372-2373.
27. GRAS chemicals list. .
28. SAINT-Plus, version 6.45. 2003. Madison, Wisconsin: Bruker AXS Inc.
29. Sheldrick GM. 1997. SADABS, Program for Empirical Absorption Correction of Area Detector Data. Göttingen, Germany: University of Göttingen.
30. Sheldrick GM. 1997. SHELXS-97 and SHELXL-97, Göttingen, Germany:University of Göttingen.
31. SMART (Version 5.625) and SHELX-TL (Version 6.12). 2000. Madison, Wisconsin: Bruker AXS Inc.
32. Spek AL. 2002. PLATON, a multipurpose crystallographic tool. Utrecht, Germany: Utrecht University.
33. Barbour LJ. 1999. X-Seed, Graphical interface to SHELX-97 and POV-Ray. Missouri: University of Missouri-Columbia.
34. PowderCell, a program for structure visualization, powder pattern calculation and profile fitting, .
35. Glomme A, Marz J, Dressman JB. 2005. Comparison of miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities. J Pharm Sci 94:1-16.
36. The International Pharmacopoeia. 3rd ed. Geneva: WHO; 2003.